What dose should a 33.6 kg child who has been taking 10 mg of atomoxetine (Strattera) for two weeks be increased to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Atomoxetine Dose Escalation After Two Weeks

Increase the dose to approximately 40 mg daily (1.2 mg/kg/day for this 33.6 kg child), which can be given as a single morning dose or split into two doses.

Dosing Algorithm

The FDA-approved titration schedule for atomoxetine follows a weight-based approach 1:

Initial Phase (Completed):

  • Starting dose: ~0.5 mg/kg/day for minimum 3 days
  • This child received 10 mg daily (~0.3 mg/kg/day) for 2 weeks

Target Dose (Next Step):

  • Increase to 1.2 mg/kg/day after the initial period
  • For a 33.6 kg child: 1.2 × 33.6 = 40 mg daily
  • This is the standard target dose that demonstrates optimal efficacy 1, 2

Maximum Dose (If Needed Later):

  • 1.4 mg/kg/day or 100 mg/day, whichever is lower 3
  • For this child: maximum would be 47 mg daily

Dosing Schedule Options

You have two evidence-based approaches for administering the 40 mg dose:

  1. Once-daily morning dosing - Effective and convenient 1
  2. Divided dosing (morning and late afternoon/evening) - May reduce gastrointestinal side effects 4

The divided dosing approach (20 mg twice daily) is preferable when initiating the target dose, as studies show significantly lower rates of decreased appetite (8.0% vs 14.3%) and somnolence (4.2% vs 14.3%) compared to once-daily rapid titration 4.

Critical Titration Considerations

Slower titration reduces early adverse events. Research demonstrates that reaching 1.2 mg/kg/day over 2 weeks with twice-daily dosing produces fewer side effects in the first two weeks compared to rapid 3-day titration 4. Since this child has already been on a subtherapeutic dose for 2 weeks, you can now safely advance to the target dose.

The 1.2 mg/kg/day dose is the therapeutic sweet spot. Clinical trials consistently show that 1.2 mg/kg/day and 1.8 mg/kg/day produce equivalent efficacy, but the higher dose offers no additional benefit 1, 2. The 0.5 mg/kg/day dose (what this child approximates now) was not superior to placebo 1.

Expected Timeline for Response

Full therapeutic effects require patience. Unlike stimulants that work within hours, atomoxetine requires:

  • 6-12 weeks for maximum benefit 3
  • Progressive improvement from week 6 to week 12 5
  • At 12 weeks, 50% of patients show ≥40% symptom reduction 5

Monitoring Requirements

At this dose escalation visit, assess:

  • Blood pressure and heart rate (expect mild increases of 1-4 mmHg and 1-2 bpm) 6
  • Appetite and weight (common early side effect) 6
  • Gastrointestinal symptoms (nausea, abdominal pain) 3
  • Somnolence or fatigue (particularly in first weeks) 3
  • Suicidal ideation (FDA black box warning, especially first few months) 3, 6

Common Pitfalls to Avoid

Don't increase too rapidly. The most common error is advancing to 1.2 mg/kg/day in less than one week, which significantly increases gastrointestinal side effects and somnolence 4.

Don't exceed 1.4 mg/kg/day. The 1.8 mg/kg/day dose studied in trials showed no additional efficacy over 1.2 mg/kg/day 1, 2, and higher doses only increase adverse effects.

Don't expect immediate results. Families must understand this is not a stimulant—meaningful improvement takes 6-12 weeks 3. Premature discontinuation due to "lack of efficacy" at 2-4 weeks is a frequent cause of treatment failure.

Don't abruptly discontinue if switching medications. Unlike stimulants, atomoxetine should be cross-tapered when transitioning to other ADHD medications 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.